Emily Vertosick

Emily Vertosick is a Research Fellow in the Department of Epidemiology and Biostatistics at Memorial Sloan Kettering Cancer Center (MSK). Her work focuses on biostatistical analysis and epidemiological studies in urologic oncology and clinical cancer research.

• Key affiliations: MSK, Urologic Oncology Division, Population Sciences Research Program

Her research explores treatment outcomes for BCG-unresponsive bladder cancer, telemedicine applications in clinical consent processes, and anesthesia efficacy in prostate biopsies. Publications span journals like Urologic Oncology, JCO Oncology Practice, and World Journal of Urology.

Recent studies analyze trends in telemedicine versus in-person consent practices, narcotic use reduction in biopsy procedures, and gemcitabine efficacy. Collaborative work spans 85 co-authors including Vickers, Sjoberg, and Eastham.